Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
Tumor necrosis factor alpha (TNFα) is a pleiotropic cytokine known to have contradictory roles in oncoimmunology. Indeed, TNFα has a central role in the onset of the immune response, inducing both activation and the effector function of macrophages, dendritic cells, natural killer (NK) cells, and B...
Main Authors: | María Florencia Mercogliano, Sofía Bruni, Florencia Mauro, Patricia Virginia Elizalde, Roxana Schillaci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/3/564 |
Similar Items
-
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
by: María Florencia Mercogliano, et al.
Published: (2020-04-01) -
Emerging Targeted Therapies for HER2-Positive Breast Cancer
by: María Florencia Mercogliano, et al.
Published: (2023-03-01) -
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
by: Lindsey Carlsen, et al.
Published: (2022-02-01) -
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy
by: Gian Marco Leone, et al.
Published: (2023-02-01) -
Development of specific monoclonal antibodies for the detection of natural chicken tumor necrosis factor-alpha
by: Yi Yang, et al.
Published: (2022-12-01)